Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes.

Ramsey, Scott D

Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes. [electronic resource] - Contemporary clinical trials Jan 2013 - 1-9 p. digital

Publication Type: Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, N.I.H., Extramural; Review

1559-2030

10.1016/j.cct.2012.09.003 doi


Breast Neoplasms--genetics
Clinical Trials, Phase III as Topic
Combined Modality Therapy
Female
Humans
Lymph Nodes--pathology
Lymphatic Metastasis
Randomized Controlled Trials as Topic--methods